Immune system to fight brain tumors

Research at Lund University in Sweden gives hope that one of the most serious types of brain tumour, glioblastoma multiforme, could be fought by the patients' own immune system. The tumours are difficult to remove with surgery because the tumour cells grow into the surrounding healthy brain tissue. A patient with the disease therefore does not usually survive much longer than a year after the discovery of the tumour.

The team has tested different ways of stimulating the immune system, suppressed by the tumour, with a 'vaccine'. The vaccine is based on tumour cells that have been genetically modified to start producing substances that activate the immune system. The modified (irradiated so that they cannot divide and spread the disease) have been combined with other substances that form part of the body's immune system.

The treatment has produced good results in : 75 per cent of the rats that received the treatment were completely cured of their brain tumours.

"Human biology is more complicated, so we perhaps cannot expect such good results in patients. However, bearing in mind the patients receive today, all progress is important", said doctoral student Sara Fritzell, part of the research group led by consultant Peter Siesjö.

She has previously tested combining the activation of the immune system with chemotherapy. When the chemotherapy was applied directly to the tumour site, the positive effects reinforced each other, and a huge 83 per cent of the mice survived.

"Our idea is in the future to give patients chemotherapy locally in conjunction with the operation to remove as much of the tumour as possible", said Sara Fritzell.

Peter Siesjö is currently applying for permission to carry out a clinical study on stimulation of the immune system – with or without local chemotherapy – as a treatment for patients with glioblastoma multiforme.

add to favorites email to friend print save as pdf

Related Stories

Brain tumour cells killed by anti-nausea drug

Mar 18, 2013

(Medical Xpress)—New research from the University of Adelaide has shown for the first time that the growth of brain tumours can be halted by a drug currently being used to help patients recover from the side effects of ...

Cancer treatment discovery opens tumours to immune cells

May 28, 2012

(Medical Xpress) -- Scientists at the Western Australian Institute for Medical Research (WAIMR) have made exciting progress in their quest to help patients fight cancer using the body's own immune system.The ...

Virus-like particles provide vital clues about brain tumors

Apr 17, 2013

Exosomes are small, virus-like particles that can transport genetic material and signal substances between cells. Researchers at Lund University, Sweden, have made new findings about exosomes released from aggressive brain ...

Recommended for you

Pepper and halt: Spicy chemical may inhibit gut tumors

2 hours ago

Researchers at the University of California, San Diego School of Medicine report that dietary capsaicin – the active ingredient in chili peppers – produces chronic activation of a receptor on cells lining ...

Expressive writing may help breast cancer survivors

4 hours ago

Writing down fears, emotions and the benefits of a cancer diagnosis may improve health outcomes for Asian-American breast cancer survivors, according to a study conducted by a researcher at the University of Houston (UH).

Taking the guesswork out of cancer therapy

9 hours ago

Researchers and doctors at the Institute of Bioengineering and Nanotechnology (IBN), Singapore General Hospital (SGH) and National Cancer Centre Singapore (NCCS) have co-developed the first molecular test ...

Brain tumour cells found circulating in blood

10 hours ago

(Medical Xpress)—German scientists have discovered rogue brain tumour cells in patient blood samples, challenging the idea that this type of cancer doesn't generally spread beyond the brain.

International charge on new radiation treatment for cancer

11 hours ago

(Medical Xpress)—Imagine a targeted radiation therapy for cancer that could pinpoint and blast away tumors more effectively than traditional methods, with fewer side effects and less damage to surrounding tissues and organs.

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Timothy
not rated yet May 31, 2013
There is another company who is fighting GBM by immunotherapy. The name of the company is Northwest Biotherapeutics and they have a product which is in Phase III, called DCVax-L. From earlier trials there are several patients who have been treated and who are still alive and in good shape after 10 years. In the US they currently have 47 trial locations and in in Europe they've received a priority phase 3 trial in the UK. The phase 3 trials is also eligible for compassionate use.